Alimera Sciences

ALIM · NASDAQ

Price unavailable right now.

No price history for this range.

About ALIM

Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is headquartered in Alpharetta, Georgia and currently employs 159 full-time employees. The firm is focused on helping patients, physicians and partners concerned with retinal health and maintaining better vision longer.

Employees: 157
Headquarters: Alpharetta, Georgia
Listed: Apr 22, 2010
Sector: Health Care
Industry: Pharmaceuticals
Website: alimerasciences.com

Leadership

Alimera Sciences executives
Name	Title	Since	Age
C. Daniel Myers	—	2003	69
Richard Eiswirth	—	2005	55
Elliot Maltz	—	—	38
Philip Ashman	—	—	58
Jason Werner	—	2023	45
David Holland	—	—	59
Russell Skibsted	—	—	65
Scott Gordon	—	2023	—

Revenue by product and region

Fiscal year ended Dec 31, 2023: $80.75M total revenue

By product

United States Segment [Member]$56.71M70.2%
International Segment [Member]$24.04M29.8%

Similar companies

Companies in the same industry as Alimera Sciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.